Pull to refresh
Logo
Daily Brief
Following
Why Sign Up
Karolinska Institutet

Karolinska Institutet

Research university

Appears in 1 story

Stories

GLP-1 weight-loss drugs show unexpected psychiatric benefits in largest study to date

New Capabilities

Co-produced the March 2026 study

Drugs originally designed to control blood sugar and reduce weight may also protect the brain. A study of 95,490 people in Sweden, published in The Lancet Psychiatry on March 22, 2026, found that users of semaglutide—the compound in the blockbuster drugs Ozempic and Wegovy—experienced 42% fewer psychiatric hospitalizations, 44% less worsening depression, and 47% fewer substance-use-related crises compared to periods when they were not taking the drug.

Updated Yesterday